News Releases

Date	Title
11/30/21	MIMEDX Announces Speakers for December 7 Investor Day
11/22/21	MIMEDX to Present at the Piper Sandler 33rd Annual Healthcare Conference
11/17/21	Peer Reviewed Study Demonstrates MIMEDX Dehydrated Human Amnion Chorion Membrane (dHACM) Outperforms Standard of Care in Select Mohs Defect Reconstructions
11/02/21	MIMEDX Announces Third Quarter 2021 Operating and Financial Results
11/02/21	MIMEDX to Participate at Upcoming Investor Conferences
11/01/21	Two New Studies Demonstrate in vitro Bioactivity Potential of Micronized Dehydrated Human Amnion Chorion Membrane (mdHACM) to Prevent Pathological Processes Underlying Osteoarthritis (OA) and Tendinopathy
10/20/21	MIMEDX to Host Third Quarter 2021 Operating and Financial Results Conference Call on November 3
10/14/21	MIMEDX to Host Virtual Investor Day on December 7, 2021
09/13/21	MIMEDX Reports Top-line Data from Two Late-Stage Musculoskeletal Trials with Proprietary Amniotic Tissue Technology
09/08/21	MIMEDX Announces Effectiveness of Shelf Registration Statement